Hegde R, Podder S K
Department of Biochemistry, Indian Institute of Science, Bangalore.
Arch Biochem Biophys. 1997 Aug 1;344(1):75-84. doi: 10.1006/abbi.1997.0177.
The cytotoxic lectin abrin shows more than 30 variant forms (R. Hegde, T. K. Maiti, and S. K. Podder, 1991, Anal. Biochem. 194, 101-109). The lectin B subunit as cause for variance in abrins I and III was detected by a combination of one- and two-dimensional electrophoresis and Western blotting. Intriguingly, in abrin I but not in abrin III, association of a single A subunit with the variant B subunits shifts the holoprotein pI toward the alkaline side indicating that the subunit association involves neutralization of few negative charges. The B-subunit variants of abrins I and III overlap in their pI, and the A-subunit association gives the holoproteins a distinctness on isoelectric focusing gel. The results were also confirmed by analyzing the pH titration curves. These differences in the subunit association pattern between abrins I and III are in corroboration with the previously observed differences in the kinetics of protein synthesis inactivation and accessibility of the disulfide bridge to reducing agents in the presence or absence of putative receptor (R. Hegde, A. Karande, and S. K. Podder, 1993 Eur. J. Biochem. 215, 411-419). Further, the genetic origin of variance was confirmed by peptide mapping of the individual subunit variants. Considering a theoretical value of 0.1 to 0.2 pI/charge, a 15-17 charge difference could be predicted between the variants of two extreme pIs. The fact that the A subunits are not shared between the groups was taken to interpret that the protein synthesized as prepro form is processed posttranslationally and the processing takes place only after the disulfide bond formation between A and B subunits. The N-terminal 16 amino acids of A subunits of abrins I and III showed 26% dissimilarity. The A subunits of abrins I and III did not react with concanavalin A, indicating that the heterogeneity in the molecular weight is because of differential processing but not because of glycosylation.
细胞毒性凝集素相思子毒素显示出30多种变体形式(R. Hegde、T. K. Maiti和S. K. Podder,1991年,《分析生物化学》194卷,第101 - 109页)。通过一维和二维电泳以及蛋白质免疫印迹相结合的方法检测到凝集素B亚基是相思子毒素I和III变异的原因。有趣的是,在相思子毒素I而非相思子毒素III中,单个A亚基与变异B亚基的结合使全蛋白的等电点向碱性一侧移动,这表明亚基结合涉及少量负电荷的中和。相思子毒素I和III的B亚基变体在等电点上有重叠,而A亚基的结合使全蛋白在等电聚焦凝胶上具有独特性。通过分析pH滴定曲线也证实了这些结果。相思子毒素I和III之间亚基结合模式的这些差异与之前观察到的在蛋白质合成失活动力学以及在存在或不存在假定受体的情况下二硫键对还原剂的可及性方面的差异相一致(R. Hegde、A. Karande和S. K. Podder,1993年,《欧洲生物化学杂志》215卷,第411 - 419页)。此外,通过对各个亚基变体进行肽图谱分析证实了变异的遗传起源。考虑到理论值为0.1至0.2等电点/电荷,在两个极端等电点的变体之间可预测有15 - 17个电荷差异。两个组之间不共享A亚基这一事实被用来解释以前体形式合成的蛋白质在翻译后进行加工,并且加工仅在A和B亚基之间形成二硫键之后发生。相思子毒素I和III的A亚基的N端16个氨基酸显示出26%的差异。相思子毒素I和III的A亚基不与伴刀豆球蛋白A反应,这表明分子量的异质性是由于不同的加工而非糖基化。